18569810. NOVEL UREA DERIVATIVE COMPOUND AS RON INHIBITOR simplified abstract (LG Chem, Ltd.)
NOVEL UREA DERIVATIVE COMPOUND AS RON INHIBITOR
Organization Name
Inventor(s)
Joong Heui Cho of Daejeon (KR)
Young Shin Kwak of Daejeon (KR)
Gyeong Hwan Kim of Daejeon (KR)
NOVEL UREA DERIVATIVE COMPOUND AS RON INHIBITOR - A simplified explanation of the abstract
This abstract first appeared for US patent application 18569810 titled 'NOVEL UREA DERIVATIVE COMPOUND AS RON INHIBITOR
The present invention introduces a new compound that acts as a protein kinase inhibitor, specifically targeting RON.
- The compound is designed to inhibit the activity of the RON protein kinase.
- This innovation offers a potential new approach for treating diseases or conditions where RON kinase activity is implicated.
- The compound may have applications in cancer treatment, as RON kinase is known to play a role in cancer progression.
- By specifically targeting RON kinase, this compound may offer a more targeted and effective treatment option with potentially fewer side effects.
- This innovation could lead to the development of novel therapeutics for various diseases beyond cancer where RON kinase is involved.
Potential Applications: - Cancer treatment - Development of targeted therapies for diseases involving RON kinase activity
Problems Solved: - Providing a more targeted approach to inhibiting RON kinase activity - Potentially reducing side effects associated with broad-spectrum kinase inhibitors
Benefits: - More effective treatment options for diseases involving RON kinase - Potential for improved patient outcomes with reduced side effects
Commercial Applications: Title: Novel Compound for Targeted Protein Kinase Inhibition in Cancer Treatment This innovation could have significant commercial applications in the pharmaceutical industry, particularly in the development of targeted therapies for cancer and other diseases involving RON kinase activity.
Questions about the Novel Compound for Targeted Protein Kinase Inhibition in Cancer Treatment: 1. How does this compound specifically target RON kinase activity? 2. What sets this compound apart from existing protein kinase inhibitors in terms of efficacy and safety profiles?
Original Abstract Submitted
The present invention relates to a novel compound as a protein kinase inhibitor, a RON inhibitor in particular.
